Synaptic vesicle glycoprotein 2A is a ubiquitous synaptic vesicle protein that in humans is encoded by the SV2A gene. The protein is targeted by the anti-epileptic drugs (anticonvulsants) levetiracetam and brivaracetam. See also SV2B References Further reading External links